Dupuytren’s Contracture Market Size | Industry Forecast By 2030 (2023)

Upcoming Dupuytren’s Contracture Market Size | Industry Forecast By 2030 (1)

Dupuytren’s Contracture Market


Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Dupuytren’s Contracture Market

Request Now !

(Video) 180 Life Sciences Corp describes recent milestones with lead indication in Dupuytren’s disease

Dupuytren's contracture is a condition in which there is difficulty in articulating the fingers of the hand due to formation of tissue knots beneath the skin. The fingers become permanently bent in a flexed position in severe condition. Dupuytren's contracture is not painful and most commonly affects the ring finger followed by the little and middle fingers. It has a higher rate in males over the age of 50. The exact causes of Dupuytren's contracture are unknown, however, the risk factors include thyroid problems, alcoholism, liver disease, smoking, diabetes, epilepsy, previous hand trauma, and family history. The surgery is performed when the proximal interphalangeal joint contracture exceeds 20 degrees or the metacarpophalangeal joint contracture exceeds 40 degrees. The less severe forms of the Dupuytren's contracture disease are treated with steroid treatment and physiotherapy.

COVID-19 Impact Analysis

COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

(Video) Value creation in Life Sciences 26 : Musings with Sylvain Sachot

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the Dupuytren’s contracture market.

Top Impacting Factors

Increase in geriatric population leading to rise in patient population is the key driver of the global Dupuytren’s contracture market. In addition, rise in cardiac cases such as heart attack, other factors includes cancer, kidney failure, end-stage lung cancer, and hypothyroidism boosts the market growth. Moreover, rise in screening and increase in healthcare expenditure propel the growth of the Dupuytren’s contracture market.

In addition, rise in awareness about health and government initiatives to improve healthcare infrastructure are some factors that boosts the market growth. Moreover, increase in awareness about cardiac diseases can propel the growth of the market.

Furthermore, ongoing research & developments for creating efficient and availability of cost-effective treatments boosts the market growth.

However, complications and risk associated with Dupuytren’s contracture surgery and invasive nature of the treatment restrain the growth of the market.

Market Trends

New Product Launches to Flourish the Market

In September 2019, Endo International Plc. announced four new studies of XIAFLEX (collagenase clostridium histolyticum), including real-world data, for the treatment of Dupuytren's contracture. XIAFLEX is indicated for the treatment of adult patients with Dupuytren's contracture with a palpable cord.

(Video) Improving DISCOM viability through behind-the-meter Energy Efficiency & Renew. Energy interventions

In April 2018, Paladin Labs Inc. announced the launch of a new indication for XIAFLEX (collagenase clostridium histolyticum), the first and only Health Canada-approved treatment for appropriate patients with peyronie's disease with palpable plaque and curvature deformity of at least 30 degrees at the start.

Key Benefits of the Report

  • This study presents the analytical depiction of the Dupuytren’s contracture market industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the market share.
  • The current market is quantitatively analyzedto highlight the market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed market analysis depending on competitive intensity and how the competition will take shape in coming years.

Questions Answered in the Dupuytren’s Contracture Market Report

  • Which are the leading players active in the Dupuytren’s contracture market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What is Dupuytren’s contracture market?
  • What is Dupuytren’s contracture market prediction in the future?
  • Who are the leading global players in the Dupuytren’s contracture market?
  • What are the current trends and predicted trends?
  • What are the key benefits of the Dupuytren’s contracture market report?

Dupuytren’s Contracture Market Report Highlights

Aspects Details
By Type
  • Type I
  • Type II
  • Type III
By Diagnosis
  • Physical Examination
  • X-Ray
  • Others
By End User
  • Hospitals
  • Clinics
  • Academic and Research
  • Others
By Region
  • North America (U.S., Canada, Mexico)
  • Europe (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Bristol-Meyers Squibb Co., Fresenius Kabi AG, Merck Sharp & Dohme Corp., Pfizer Inc., West-Ward Pharmaceuticals, Spear Pharmacueticals, Actiza Pharmaceutical Private Limited, Nantong Jinghua Pharmaceutical Co., Ltd., Endo International plc.

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.



What percentage of the population has Dupuytren's contracture? ›

Dupuytren contracture occurs in about 5 percent of people in the United States. The condition is 3 to 10 times more common in people of European descent than in those of non-European descent.

Is Dupuytren's an industrial disease? ›

Dupuytren's contracture, often referred to as 'Claw hand' or 'Miners claw', is generally caused as a result of the regular use of vibratory power tools and heavy industrial equipment, common in construction and mining.

What famous people have Dupuytren's contracture? ›

Dupuytren celebrities include politicians Ronald Reagan, Margaret Thatcher, Mitt Romney, actor Paul Newman, singer Frank Sinatra, comedians Bill Murray, Chelsea Handler, and many, many others – in all walks of life.

How many people have Dupuytren's? ›

A Dupuytren biomarker is needed to predict this on an individual basis. About 15 million Americans age 35 and older have Dupuytren disease. This accounts for 5% of the entire US population of 309 million. It accounts for 9.3% of the 163 million at-risk Americans aged 35 and older.

What nationality has Dupuytren's contracture? ›

Dupuytren's disease is common in Norway and northern Europe but rare in individuals who are not of European descent. The aboriginal Sami of the northernmost parts of Scandinavia are ethnically distinct from most Norwegians.

Is Dupuytren's considered an autoimmune disease? ›

In terms of the immunological features of DD, evidence has persistently suggested the involvement of both T and B lymphocytes in DD etiology [7, 38]. As such, the disease has frequently been termed a “T-cell-mediated autoimmune disorder” [6].

Can I claim benefits for Dupuytren's contracture? ›

To be eligible for Industrial Injuries Disablement Benefit (IIDB) for Dupuytren's contracture you must have: been employed. used hand-held vibrating tools for at least 10 years.

Is Dupuytren's contracture classed as a disability? ›

This condition causes a limited range of motion in one or both hands. This complication can result in an inability to perform work tasks. If the condition is severe enough to prohibit them from working, individuals suffering from the condition can apply for Social Security disability insurance.

Is Dupuytren's caused by diabetes? ›

Dupuytren's contracture can be considered a complication of diabetes and of the local neurovascular changes since both are often associated. The contracture is usually not severe in diabetes, is nodular in form, and usually crushes the palmar surface of the long and ring fingers.

Is Dupuytren's contracture linked to Vikings? ›

Tradition has it that the disease originated with the Vikings, who spread it throughout Northern Europe and beyond as they traveled and intermarried. After being present for hundreds of years, DD was named in the 19th century after a famous French surgeon, who was not the first to describe it.

What diseases is Dupuytren's related to? ›

Dupuytren disease is a genetic disorder that often is inherited in an autosomal dominant fashion, but is most frequently seen with a multifactorial etiology. It is associated with diabetes, seizure disorders, smoking, alcoholism, HIV, and vascular disease.

Does Dupuytren's contracture skip a generation? ›

Dupuytren often runs in families but can skip several generations. One-fourth of Dupuytren patients don't know anyone in their family with it.

Is Dupuytren's surgery worth it? ›

It is safe and effective, but may not always be necessary. Other treatments are available, depending on the severity of the condition. Usually, the earlier Dupuytren's contracture is identified, the more treatment options are available.

How successful is Dupuytren's surgery? ›

Subtotal palmar fasciectomy

Recovery is likely to involve not only a skin graft but also physical therapy. Although Dupuytren's is incurable, surgery for the condition has a high rate of positive outcomes. The vast majority of people who have Dupuytren's surgery regain much of the movement in their fingers.

Do African Americans get Dupuytren's contracture? ›

There is general agreement that Dupuytren's contracture is a genetic disorder that occurs predominantly in white men of Northern European ancestry. It appears rarely in the purely black population.

Who is more likely to get Dupuytren's contracture? ›

Dupuytren contracture occurs most commonly after the age of 50. Sex. Men are much more likely to develop Dupuytren than are women. In men, symptoms may be worse and progress more quickly.

Can you stop the progression of Dupuytren's contracture? ›

There is no cure for Dupuytren's contracture. The condition is not dangerous. Many people don't get treatment. But treatment for Dupuytren's contracture can slow the disease or help ease your symptoms.

What is the most common crippling hand condition you ve never heard of? ›

The 'most common crippling hand condition' you've never heard of. Dupuytren's contracture may be mistaken for arthritis or tendinitis, or go unnoticed until the fingers start to bend.

How fast does Dupuytren's disease progress? ›

A Dupuytren's contracture typically progresses very slowly, over a period of years. Signs and symptoms of the condition may include: Nodules. You may develop one or more small lumps, or nodules, in the palm of your hand.

Top Articles
Latest Posts
Article information

Author: Greg Kuvalis

Last Updated: 04/12/2023

Views: 5733

Rating: 4.4 / 5 (55 voted)

Reviews: 86% of readers found this page helpful

Author information

Name: Greg Kuvalis

Birthday: 1996-12-20

Address: 53157 Trantow Inlet, Townemouth, FL 92564-0267

Phone: +68218650356656

Job: IT Representative

Hobby: Knitting, Amateur radio, Skiing, Running, Mountain biking, Slacklining, Electronics

Introduction: My name is Greg Kuvalis, I am a witty, spotless, beautiful, charming, delightful, thankful, beautiful person who loves writing and wants to share my knowledge and understanding with you.